GENinCode (LON:GENI) Stock Price Down 6.1% – Should You Sell?

GENinCode Plc (LON:GENIGet Free Report) shares dropped 6.1% during trading on Friday . The stock traded as low as GBX 4.71 ($0.06) and last traded at GBX 5.45 ($0.07). Approximately 3,874,959 shares traded hands during mid-day trading, an increase of 156% from the average daily volume of 1,513,098 shares. The stock had previously closed at GBX 5.80 ($0.07).

GENinCode Stock Down 17.2 %

The company has a fifty day moving average of GBX 3.85 and a 200 day moving average of GBX 5.12. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.27. The company has a market cap of £8.49 million, a P/E ratio of -96.00 and a beta of 0.66.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

See Also

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.